Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10006)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
MEN1
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Stearoyl-CoA desaturase (SCD) [Suppressor]
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
Target for Ferroptosis | Suppressor | |||
Responsed Disease | Pancreatic cancer | ICD-11: 2C10 | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Cell Process | Cell ferroptosis | |||
In Vitro Model |
BON-1 cells | Pancreatic serotonin-producing neuroendocrine tumor | Homo sapiens | CVCL_3985 |
QGP-1 cells | Pancreatic somatostatinoma | Homo sapiens | CVCL_3143 | |
Response regulation | We show that stearoyl-coA desaturase (SCD1) is the downstream of MEN1-mTOR signaling and oleic acid (OA), a metabolite of SCD1, recues the lipid peroxidation caused by MEN1 overexpression. The negative correlation between MEN1 and SCD1 is further verified in clinical specimens. Furthermore, we find that BON-1 and QGP-1 cells with MEN1 overexpression are more sensitive to everolimus, a widely used drug in pNETs that targets mTOR signaling. | |||
Pancreatic cancer [ICD-11: 2C10]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
Target Regulator | Menin (MEN1) | Protein coding | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Cell Process | Cell ferroptosis | |||
In Vitro Model |
BON-1 cells | Pancreatic serotonin-producing neuroendocrine tumor | Homo sapiens | CVCL_3985 |
QGP-1 cells | Pancreatic somatostatinoma | Homo sapiens | CVCL_3143 | |
Response regulation | We show that stearoyl-coA desaturase (SCD1) is the downstream of MEN1-mTOR signaling and oleic acid (OA), a metabolite of SCD1, recues the lipid peroxidation caused by MEN1 overexpression. The negative correlation between MEN1 and SCD1 is further verified in clinical specimens. Furthermore, we find that BON-1 and QGP-1 cells with MEN1 overexpression are more sensitive to everolimus, a widely used drug in pNETs that targets mTOR signaling. | |||